A Phase I/II Study of Gilteritinib and Momelotinib for Patients with Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia: A Trial in Progress

被引：0

作者：

Short, Nicholas J. ^{[1
]}

Ravandi, Farhad

Daver, Naval ^{[2
]}

Dinardo, Courtney D. ^{[1
]}

Borthakur, Gautam ^{[3
]}

Kadia, Tapan M.

Yilmaz, Musa ^{[1
]}

Issa, Ghayas C. ^{[1
]}

Abramova, Regina ^{[4
]}

Garza, Araceli Isabella ^{[1
]}

Kantarjian, Hagop M. ^{[1
]}

Abbas, Hussein A. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA

[2] MD Anderson Canc Ctr, Houston, TX USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX USA

[4] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

来源：

关键词：

D O I：

10.1182/blood-2024-200923

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2